SecBot SecBot
SECBOTREPLAY Home › Report › NMRA

NMRA · Neumora Therapeutics announced it will report its Q4 and full-year 2025…

Neumora Therapeutics, Inc. · PRESS-RELEASE filed Mar 16, 2026 at 07:00 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 16, 2026 at 07:00 ET

Neumora Therapeutics announced it will report its Q4 and full-year 2025 financial results on March 30, 2026, via a live webcast and conference call. No financial data was released in this announcement, it is solely a press release notifying investors of an upcoming earnings event.

  • Neumora Therapeutics will report Q4 and full-year 2025 financial results on March 30, 2026.
  • Event will include a conference call and live webcast at 8:00 a.m. ET.
  • No financial results or business updates were disclosed in this press release.
  • Replay will be available on the company's website for up to 30 days.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access